Mode
Text Size
Log in / Sign up
N/A Completed N=82

Facilitators and Barriers to Cancer Screening: Stakeholder Perspectives on Implementation

Source: ClinicalTrials.gov NCT04683744 ↗
Enrolled (actual)
82
Serious AEs
0.0%
Results posted
Jan 2025
Primary outcomePrimary: Facilitators and Barriers to Implementing Decision Aids, Provider Notifications, and Personal Risk Calculation Using an Electronic Health Record (EHR) to Promote Colorectal Cancer Screening. — 8; 6 Themes

Summary

The rate of screening for colorectal cancer (CRC) in the U.S. remains low (under 65%), meaning that thousands of people die of colorectal cancer unnecessarily. Colorectal cancer screening tests range from more invasive and very sensitive for polyps and cancer (colonoscopy) to less invasive and less sensitive (e.g., fecal immunochemical testing (FIT)). Screening rates go up when patients consider all these tests, not just colonoscopy. Informing patients about their options for CRC screening could produce higher quality decisions, improve the match between patient preferences and tests performed, and increase uptake of CRC screening. Decision aids (DAs) are a promising tool for accomplishing this goal. Also, precision CRC prevention - providing information about an individual's specific risk for CRC - has great promise to increase uptake and improve decision making. Unfortunately, the COVID-19 pandemic is causing severe challenges to providing CRC screening and other prevention services. Health systems are trying to adapt, but these efforts have only begun and are poorly understood. Moreover, patient perceptions of disease risk and risk from COVID-19 are unknown.

Outcome Measures

OutcomeResultp-value
PRIMARY
Facilitators and Barriers to Implementing Decision Aids, Provider Notifications, and Personal Risk Calculation Using an Electronic Health Record (EHR) to Promote Colorectal Cancer Screening.
8; 6
PRIMARY
Challenges and Facilitators of Effective Cancer Screening and Prevention in Primary Care During the COVID-19 Pandemic Among Leadership, Providers, and Staff.
5
PRIMARY
Number of Themes Identified by Patients That Influenced Decisions to Engage in Cancer Screening and Other Healthcare Services, and What Information Was Needed for Making Healthcare Decisions During the COVID-19 Pandemic.
3; 3; 4; 4; 3; 3

Eligibility Criteria

Inclusion Criteria

Health system participants will be eligible if:

  • they are employed by one of the study team's partner healthcare systems.

Patient participants will be eligible if:

  • they have had a primary care visit during the past 24 months
  • they have completed cancer screening during the past 5 years prior to 2020 for breast, cervical or lung cancer as noted in the electronic health record (EHR)
  • age 50 years or older
  • speaks English
  • accessible by phone.

Exclusion Criteria

Patients will be excluded if:

  • they did not complete any cancer screening for breast, colon, cervical, or lung cancer during the past 5 years prior to 2020
  • did not complete a primary care visit at a partner healthcare system during the past 2 years.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04683744). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search